The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
analyzed quantitatively. A dose dependent induction <strong>of</strong> DNA breaks and pyrimidine<br />
dimers was characterized using an adapted protocol <strong>of</strong> the single cell gel electrophoresis<br />
(comet assay). P53 accumulation measured with an ELISA, 5 hours<br />
post UV exposure, was shown to reach a plateau by exposure times over 15 minutes.<br />
By then, the apoptosis rate related to Caspase-3 activity, measured 18 hours<br />
post exposure, started to increase. Finally, quantitative RT-PCR on genes controlled<br />
by p53 showed that (i) p21 and GADD45 were induced; (ii) whereas a clear induction<br />
<strong>of</strong> MDM2 required relatively high UV doses. This study shows that reconstructed<br />
skin is a useful tool as part <strong>of</strong> in vitro strategies for the assessment <strong>of</strong> photoprotection<br />
and photogenotoxicity.<br />
497 MST2000 - A NEW RECONSTRUCTED HUMAN<br />
EPIDERMIS WITH INTEGRATED FUNCTIONAL<br />
PRIMARY MELANOCYTES.<br />
J. J. H<strong>of</strong>fmann 1 , B. Becker 1 , A. Thiemann 2 , S. Weimans 2 , E. Heisler 2 and H.<br />
W. Fuchs 1 . 1 R & D, CellSystems Biotechnologie Vertrieb GmbH, St. Katharinen,<br />
Germany and 2 Laboratorium für Toxikologie und Ökologie, Evonik Stockhausen<br />
GmbH, Krefeld, NRW, Germany. Sponsor: B. De Wever.<br />
<strong>The</strong> development <strong>of</strong> new active compounds for skin bleaching and tanning are important<br />
issues for the cosmetic and pharmaceutical industry. However active ingredients<br />
have to be tested extensively for their efficacy and product safety. <strong>The</strong> aim <strong>of</strong><br />
the present study was to create a reconstructed epidermis containing keratinocytes<br />
and melanocytes as a tool especially for efficacy studies. Based on the technology <strong>of</strong><br />
the Epidermal Skin Test - EST1000 (CellSystems® Biotechnologie Vertrieb<br />
GmbH, Germany) several batches <strong>of</strong> skin models with different ratios <strong>of</strong><br />
melanocytes and keratinocytes were produced and characterised.<br />
This characterisation included histological examinations to investigate the structural<br />
properties <strong>of</strong> the epidermis and immunohistochemical staining <strong>of</strong> the<br />
melanocytes by using anti-HMB45 antibodies.<br />
An important feature for testing effects on skin pigmentation is the feasibility <strong>of</strong><br />
cultivating the models for at least ten days after substance application without significant<br />
loss <strong>of</strong> viability. <strong>The</strong>refore, the models were cultured for different periods at<br />
the air liquid interphase followed by a standard MTT assay to determine their viability.<br />
Finally the melanin content for each test approach was measured.<br />
Increasing melanin contents were observed after direct UV-radiation which additionally<br />
lead to a visible tanning <strong>of</strong> the epidermis. This effect was strongly affected by<br />
several active ingredients that (i.a.) were known to directly inhibit tyrosinase activity.<br />
We conclude from these results that the newly developed melanocyte containing<br />
epidermal model is a useful tool for research and for characterisation <strong>of</strong> skin tanning<br />
or bleaching substances and for cognate applications which require model systems<br />
with melanocytes.<br />
498 IN VITRO PREDICTION OF THE VALIDATED<br />
SKINETHIC RHE 42 BIS SKIN IRRITATION TEST<br />
METHOD FOR THE GLOBALLY HARMONIZED<br />
SYSTEM (GHS) OF CLASSIFICATION AND LABELLING<br />
OF CHEMICALS.<br />
A. de Brugerolle de Fraissinette 1 , C. Tornier 1 , J. Cotovio 2 , J. Meunier 2 and N.<br />
Alépée 2 . 1 SkinEthic Laboratories, Nice, France and 2 L’Oréal, Aulnay sous Bois,<br />
France. Sponsor: G. Nohynek.<br />
European legislations have heightened the need for scientifically validated in vitro<br />
skin irritation test to replace the regulatory Draize eye irritation test. <strong>The</strong> SkinEthic<br />
Reconstructed Human Epidermis (RHE) “42 bis” test method was recognized as a<br />
stand alone test to assess the acute skin irritation by ECVAM by discriminating two<br />
categories, irritant and non irritant substances, according to the European<br />
Classification System (ESAC Statement, November 2008). An adaptation <strong>of</strong> the<br />
Global Harmonization System (GHS) by the European Union (EU) has conducted<br />
to a new EU-GHS Classification. According to the new rules for classification, the<br />
cut <strong>of</strong>f score to distinguish between no category to category 2 substances was<br />
shifted to 2.3 from 2.0 (former EU system). Consequently, test substances with in<br />
vivo scores between 2 and 2.3 are now considered as non-irritants. <strong>The</strong> aim <strong>of</strong> the<br />
study was to determine in vitro prediction <strong>of</strong> the SkinEthic RHE test method. For<br />
this purpose, the global performances <strong>of</strong> the test method were recalculated on a<br />
large set <strong>of</strong> test substances representative <strong>of</strong> different physico-chemical properties<br />
(including the catch-up validation set). <strong>The</strong> predictive capacity values (specificity,<br />
sensitivity and accuracy) were at least comparable to the required predictive values<br />
criteria defined by ECVAM as described in the Skin irritation background document.<br />
<strong>The</strong>refore, the SkinEthic RHE test method was considered as a test method<br />
adopted in the draft in vitro skin iritation OECD Test Guideline.<br />
499 MEETING REQUIREMENTS OF THE NEW OECD TG<br />
404 FOR IN VITRO SKIN IRRITATION TESTING:<br />
REPRODUCIBILITY OF THE EPIDERM SKIN<br />
IRRITATION TEST (EPIDERM-SIT) FOLLOWING THE<br />
ECVAM VALIDATION AND ACCEPTANCE AS A FULL<br />
REPLACEMENT METHOD.<br />
M. Klausner, H. Kandarova, P. J. Hayden, J. Kubilus and J. E. Sheasgreen.<br />
MatTek Corp, Ashland, MA.<br />
In autumn 2007, an international validation study was performed to evaluate the<br />
reproducibility and confirm the predictive ability <strong>of</strong> the EpiDerm Skin Irritation<br />
Test (SIT) method. In November 2008, ECVAM endorsed the EpiDerm SIT as a<br />
full replacement method for the in vivo rabbit skin irritation test. As reflected draft<br />
OECD guidelines for skin irritation testing (TG 404), US and EU regulators have<br />
appropriately maintained that a test method must demonstrate reproducibility on<br />
an ongoing basis so that regulators and commercial end users are assured that the<br />
assay method is stable and continues to give valid test results over time. <strong>The</strong> purpose<br />
<strong>of</strong> the present study was to investigate the reproducibility <strong>of</strong> the EpiDerm SIT<br />
post-validation. Over a 4-month period in 2009, 12 independent lots <strong>of</strong> EpiDerm<br />
tissue were exposed to 3 irritants (alpha terpineol, heptanal, and butyl methacrylate),<br />
3 non-irritants (benzyl benzoate, benzyl salicylate, and isopropanol) and the<br />
positive control (sodium dodecyl sulphate) and negative control (Dulbecco’s phosphate<br />
buffered saline) using the SIT protocol. As per the SIT method, tissue viability<br />
was determined using the robust and cost effective MTT assay following a single,<br />
60-minute exposure and 42-hour post-exposure incubation. In all cases, the<br />
SIT method correctly identified the irritants and non-irritants. Coefficients <strong>of</strong> variation<br />
(CV) between the tests (n=12) for the tissue viability for all test articles were<br />